Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for technology industry professionals · Thursday, November 15, 2018 · 468,333,850 Articles · 3+ Million Readers

Akoustis Announces Pricing of Offerings of Common Stock and Convertible Senior Notes

Charlotte, N.C., Oct. 19, 2018 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), a manufacturer of patented bulk acoustic wave (“BAW”) high-band RF filters for mobile and other wireless applications, today announced that it has priced its underwritten offerings of 7,250,000 shares of its common stock at a public offering price of $4.25 per share and $10 million aggregate principal amount of its 6.5% Convertible Senior Notes due 2023.  Neither offering is contingent on the completion of the other offering.

Akoustis has granted the underwriters in the common stock offering a 30-day option to purchase up to 1,087,500 additional shares of common stock solely to cover over-allotments.  Akoustis expects to close the offerings, subject to market and other conditions, on or about October 23, 2018.

Akoustis expects the gross proceeds from these offerings to be approximately $40.8 million (or approximately $45.4 million if the underwriters exercise their over-allotment option with respect to the common stock offering in full), before deducting the underwriting discount and other estimated offering expenses.   

Akoustis intends to use the net proceeds from the proposed offerings to fund operations and the growth of its business, including for capital expenditures, working capital, research and development, the commercialization of its technology and other general corporate purposes. 

Oppenheimer & Co. Inc. is acting as sole book-running manager for the common stock offering and sole underwriter for the notes offering.  National Securities Corporation, Aegis Capital Corporation, Lake Street Capital Markets and Loop Capital are acting as co-managers in connection with the common stock offering.

The notes will be unsecured and will rank pari passu with Akoustis’ outstanding unsubordinated liabilities. The notes will be convertible into common stock at the option of the holder at any time prior to maturity at an initial rate of 196.08 shares of the Company’s common stock per $1,000 principal amount of notes, which is equal to an initial conversion price of $5.10. The notes will mature on November 30, 2023 unless earlier converted, redeemed or repurchased. Interest on the notes will accrue at the rate of 6.5% per year and be payable on each February 28, May 31, August 31 and November 30, beginning February 28, 2019. The notes will include provisions relating to a put right of the holders, a redemption right of the Company and payments to be made in the event of conversion in connection with certain “qualifying fundamental change,” in each case upon the terms and subject to the provisions of the indenture under which the notes will be issued.

A shelf registration statement relating to the shares of common stock and the notes to be issued in the proposed offerings was filed with the Securities and Exchange Commission (the “SEC”) and is effective. A preliminary prospectus supplement and accompanying prospectus describing the terms of each of the proposed offerings have been filed with the SEC and a final prospectus supplement with respect to each offering will be filed with the SEC.  Copies of the final prospectus supplements and the accompanying prospectuses relating to the securities being offered may be obtained, when available, from Oppenheimer & Co. Inc. Attention: Syndicate Prospectus Department, 85 Broad Street, 26th Floor, New York, NY 10004, or by telephone at (212) 667-8563, or by email at  Electronic copies of the final prospectus supplements and accompanying prospectuses will also be available on the SEC's website at

This press release does not constitute an offer to sell, or the solicitation of an offer to buy these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted.

/EIN News/ -- About Akoustis Technologies, Inc.

Akoustis® ( is a high-tech BAW RF filter solutions company that is pioneering next-generation materials science and microelectromechanical systems (“MEMS”) wafer manufacturing to address the market requirements for improved RF filters - targeting higher bandwidth, higher operating frequencies and higher output power compared to incumbent polycrystalline BAW technology deployed today. The Company utilizes its proprietary XBAW manufacturing process to produce BAW RF filters for mobile and other wireless markets, which facilitate signal acquisition and accelerate band performance between the antenna and digital back end. Superior performance is driven by the significant advances of high-purity, single-crystal and associated piezoelectric materials and the resonator-filter process technology which drives electro-mechanical coupling and translates to wide filter bandwidth. 

Akoustis plans to service the fast growing multi-billion-dollar RF filter market using its integrated design and manufacturing (“IDM”) business model. The Company owns and operates a 120,000 sq. ft. ISO-9001:2015 certified commercial wafer-manufacturing facility located in Canandaigua, NY, which includes a class 100 / class 1000 cleanroom facility - tooled for 150-mm diameter wafers - for the design, development, fabrication and packaging of RF filters, MEMS and other semiconductor devices. Akoustis Technologies, Inc. is headquartered in the Piedmont technology corridor near Charlotte, North Carolina.

Forward-Looking Statements

This document includes “forward-looking statements” within the meaning of Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be covered by the “safe harbor” created by those sections. These forward-looking statements include, but are not limited to, statements regarding the expected offerings of common stock and notes and the intended use of the net proceeds of these offerings. Forward-looking statements include all statements that are not historical facts and typically are identified by use of terms such as "may," "will," "should," "could," "expect," "plan," "anticipate," "believe," "estimate," "predict," “intend,” “forecast,” “seek,” "potential," "continue" and similar words, although some forward-looking statements are expressed differently. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, these forward-looking statements are based on management’s current beliefs, expectations and assumptions and are subject to risks and uncertainties. Factors that could cause actual results to differ materially from those currently anticipated include, without limitation, risks relating to whether Akoustis will consummate the common stock offering or the notes offering; market and other general economic conditions; whether Akoustis will be able to satisfy the conditions required to close any sale of common stock or notes in the offerings; the fact that Akoustis’ management will have broad discretion in the use of the proceeds from any sale of the common stock and the notes in the offerings; the results of our research and development activities, including uncertainties relating to semiconductor process manufacturing; the development of our XBAWTM technology and products presently under development and the anticipated timing of such development; our ability to protect our intellectual property rights that are valuable to our business, including patent and other intellectual property rights; our ability to successfully manufacture, market and sell products based on our technologies; the ability to achieve qualification of our products for commercial manufacturing in a timely manner and the size and growth of the potential markets for any products so qualified; the rate and degree of market acceptance of any of our products; our ability to raise funding to support operations and the continued development and qualification of our products and the technologies underlying them; and our ability to service our outstanding indebtedness. These and other risks and uncertainties are described in more detail in the Risk Factors and Management’s Discussion and Analysis of Financial Condition and Results of Operations sections of the Company’s most recent Annual Report on Form 10-K and the Risk Factors sections of the preliminary prospectus supplements describing the terms of the proposed offerings that have been filed with the SEC. Considering these risks, uncertainties and assumptions, the forward-looking statements regarding future events and circumstances discussed in this document may not occur, and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements.  You should not rely upon forward-looking statements as predictions of future events. The forward-looking statements included in this document speak only as of the date hereof and, except as required by law, we undertake no obligation to update publicly or privately any forward-looking statements, whether written or oral, for any reason after the date of this document to conform these statements to new information, actual results or to changes in our expectations.

                    Tom Sepenzis
                    Akoustis Technologies
                    Director of Investor Relations
                    (980) 689-4961
                    The Del Mar Consulting Group, Inc.
                    Robert B. Prag, President


Powered by EIN News
Distribution channels: Technology
Submit your press release